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Kaila M. Bennett, Suzan H. M. Rooijakkers and Ronald D. Gorham Jr.*
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands
The complement system is typically regarded as an effector arm of innate immunity,
leading to recognition and killing of microbial invaders in body fluids. Consequently,
pathogens have engaged in an arms race, evolving molecules that can interfere
with proper complement responses. However, complement is no longer viewed as
an isolated system, and links with other immune mechanisms are continually being
discovered. Complement forms an important bridge between innate and adaptive
immunity. While its roles in innate immunity are well-documented, its function in
adaptive immunity is less characterized. Therefore, it is no surprise that the field of
pathogenic complement evasion has focused on blockade of innate effector functions,
while potential inhibition of adaptive immune responses (via complement) has been
overlooked to a certain extent. In this review, we highlight past and recent developments
on the involvement of complement in the adaptive immune response. We discuss the
mechanisms by which complement aids in lymphocyte stimulation and regulation, as
well as in antigen presentation. In addition, we discuss microbial complement evasion
strategies, and highlight specific examples in the context of adaptive immune responses.
These emerging ties between complement and adaptive immunity provide a catalyst for
future discovery in not only the field of adaptive immune evasion but in elucidating new
roles of complement.
Keywords: complement system, adaptive immunity, immune evasion, crosstalk, antigen presenting cell,
complement receptors
Abbreviations: aHUS, atypical hemolytic uremic syndrome; AP, alternative pathway; APC, antigen presenting cell; AT,
anaphylotoxin; B. anthracis, Bacillus anthracis; B. pertussis, Bordetella pertussis; BclA, Bacillus collagen-like protein of
anthracis; BCR, B cell receptor; C4BP, C4b-binding protein; cC1qR, collagen C1q receptor; CD46, membrane cofactor
protein; CD55, decay accelerating factor; CCP, complement control protein; CP, classical pathway; CR, complement
receptor; CRIg, complement receptor of immunoglobulin superfamily; CSP, circumsporozoite protein; CSR, class switch
recombination; CTSL, cathepsin L; DC, dendritic cell; EBV, Epstein-Barr virus; Ecb, extracellular-complement binding
protein; Efb-C, extracellular fibrinogen-binding protein; ERK, extracellular signal related kinase; F. tularensis, Francisella
tularensis; FB, factor B; FD, factor D; FH, factor H; FHA, filamentous hemagglutinin; FI, factor I; gC1qR, globular C1q
receptor; g, gp, or GP, glycoprotein; GC, germinal center; HCV, hepatitis C virus; HHV-6, human herpes virus 6; HRgpA
and RgpB, arginine-specific gingipain; HSV, herpes simplex virus; InlB, internalin B; IRF-1, interferon regulatory factor 1;
L. monocytogenes, Listeria monocytogenes; LP, lectin pathway; M. bovis BCG, Mycobacterium bovis Bacillus Calmette-
Guerin; M. leprae, Mycobacterium leprae; MAC, membrane attack complex; MAPK, mitogen-activate protein kinase; MASPs,
MBL-associated serine proteases; MBL, mannose-binding lectin; NS, non-structural protein; P. gingivalis, Porphyromonas
gingivalis; PGL-1, phenolic glycolipid 1; PI3K, phosphoinositide 3-kinase; PNH, paroxysmal nocturnal hemoglobinuria; RA,
rheumatoid arthritis; S. aureus, Staphylococcus aureus; S. pyogenes, Streptococcus pyogenes; Sbi, Staphylococcus binder of IgG;
SCIN, staphylococcal complement inhibitor; SLE, systemic lupus erythematosus; SpA, staphylococcal protein A; TCR, T
cell receptor; Th, T helper cell; TLR, Toll-like receptor; Treg, regulatory T cell; USF-1, upstream stimulating factor 1; VCP,
vaccinia control protein; WNV, West Nile virus.
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INTRODUCTION
The complement system is an evolutionarily conserved branch
of innate immunity, which is comprised of a proteolytic
cascade of numerous proteins in serum. Complement is
historically regarded as a first line of defense against invading
pathogens, and activation of the enzymatic cascade leads to
their rapid recognition and elimination. Activation of this
cascade leads to leukocyte chemotaxis, phagocytosis, and direct
cell lysis via the MAC. While complement has long been
regarded as an isolated immunological pathway, mounting
recent evidence ties complement to many other physiological
processes.
Complement is considered an important link between innate
and adaptive immunity. While its roles in innate immunity have
been well-characterized, we are only beginning to understand
the complex “crosstalk” between complement and the adaptive
immune system. Historically, complement’s only established role
in adaptive immunity was its function in humoral antibody
response, in which complement opsonization reduces the B cell
activation threshold in response to antigens, subsequently leading
to increased antibody production. Since the initial discovery
more than 40 years ago, many new roles have been described,
including antigen capture by FDCs and antigen presentation. In
the last decade, numerous studies have elucidated direct roles of
complement in T cell immunity. Moreover, new mechanisms are
continually being identified, suggesting an increasingly crucial
role of complement in directing adaptive immune responses.
While the human immune system is highly evolved to mount
an effective response to nearly any encountered threat, invading
pathogens do not give up without a fight. In a struggle for
survival, pathogens and their human hosts are engaged in a
perpetual arms race. Indeed, many immune evasion strategies
have been discovered in recent decades, and much work has
focused on complement evasion by human pathogens (reviewed
in Lambris et al., 2008; Stoermer and Morrison, 2011; Ricklin,
2012; Zipfel et al., 2013; Merle et al., 2015b; Garcia et al.,
2016). Many of the goals of pathogenic complement evasion are
clear, particularly inhibition of phagocytosis and direct killing by
MAC. However, the role of complement in directing adaptive
immune responses against pathogens is only beginning to be
understood, and how pathogens circumvent these processes is
less clear.
Herein, we describe how pathogens modulate adaptive
immunity through complement regulation. We highlight the
known mechanisms by which complement drives adaptive
immune responses, and summarize evasion strategies used by
pathogens to direct adaptive immunity through complement
engagement. Furthermore, we postulate generalized mechanisms
that pathogens can employ to subvert complement-mediated B
and T cell responses.
COMPLEMENT ACTIVATION
Complement activation proceeds via three pathways (classical,
lectin, and alternative) that, while activated via different
mechanisms, all lead to cleavage of C3, the central component
of the complement cascade, and the effector functions described
above (Figure 1). These mechanisms are briefly described
here, but are reviewed in detail elsewhere (Merle et al.,
2015a). The CP is initiated by antigen-bound IgG or IgM,
which allows binding of the C1 complex (C1qrs). The
protease component, C1s, then cleaves C4 and C2, to form
a C3 convertase (C4b2a) on a target surface. The LP is
activated in a similar manner, but rather than relying on
antibodies, MBL recognizes carbohydrate patterns conserved
among microorganisms. This binding event activates MASPs,
which, similarly to C1s, cleave C4 and C2 to form C4b2a.
The AP is spontaneously activated by hydrolysis of C3 to
form C3(H2O), which can form a complex with FB. Upon
cleavage by FD, a C3 convertase is formed [C3(H2O)Bb],
which like C4b2a, can mediate cleavage of C3 into C3a and
C3b. The newly formed C3b molecule can also form an
AP C3 convertase enzyme (C3bBb) similarly to C3(H2O).
Upon cleavage by C3 convertase enzymes, C3 undergoes a
large conformational change, whereby its intrinsic thioester
becomes exposed and can quickly react with molecules on cell
surfaces. This reaction mediates covalent cell-surface attachment
of the activated cleavage product C3b. Since C3b comprises
the C3 convertase of the AP, C3b deposition initiates an
amplification loop, which leads to rapid opsonization of the
target cell surface. Opsonization by C3b leads to several
functional outcomes. High densities of C3b on cell surfaces
can lead to formation of C5 convertase enzymes, which
cleave C5 into C5a and C5b. This event initiates formation
of MAC, which can directly mediate cell lysis. In addition,
the ATs C3a and C5a are involved in chemoattraction of
leukocytes during infection, and have been shown to play
emerging roles in regulating T cell immunity (discussed in detail
below).
Complement also has numerous regulatory mechanisms
to control complement activation, particularly on host cells
where complement activation is undesirable. Indeed, many host
cells express CD55 (DAF), which dissociates C3 convertases
and prevents further amplification. In addition, CD46 (MCP)
and CR1 (CD35) bind to C3b and serve as cofactors for
FI to cleave C3b to iC3b, which is no longer able to form
active convertase enzymes. Thus, complement activation and
amplification are slowed. These regulatory events are also
mediated by FH, a soluble complement regulator that binds to
anionic markers on host cell surfaces. Likewise, C4BP, a soluble
regulator of the CP and LP, facilitates FI-mediated cleavage of
C4b.
Breakdown of C3b plays an important role in pathogen
clearance and downstream adaptive immune response. C3b
is recognized by CR1, which is involved in clearance of
target cells and immune complexes from the bloodstream.
Concomitantly, CR1 facilitates cleavage of C3b to iC3b
[and eventually to C3d(g)], which can also interact with
several CRs on cell surfaces (including CR2, CR3, and
CR4), participating in a variety of functions including
phagocytosis, antigen presentation, and lymphocyte
stimulation.
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FIGURE 1 | Complement activation, regulation, and inhibition. The three activation pathways are shown near the corresponding yellow-shaded boxes
(classical, lectin, and APs). These pathways lead to C3b and C4b deposition, convertase, and MAC formation on the target cell surface. Breakdown mediated by
complement regulators leads to iC3b and C3dg formation. Complement receptors and regulators are depicted on the host cell surface. Interactions are indicated by
dashed black arrows, and enzymatic cleavage events are indicated by solid black arrows. Proteins listed in red boxes are immune evasion molecules that inhibit the
complement interactions indicated by the solid red arrow and red “X”. It is unknown whether MP60 (in black font) inhibits the C3d-CR2 interaction, although it binds
to C3d. A red inhibitory line indicates inhibition of protein expression. Proteins listed in green boxes with dashed green arrows bind to the indicated complement
protein, and those with solid green arrows facilitate the indicated cleavage event.
COMPLEMENT REGULATION OF
ADAPTIVE IMMUNITY
C3d-CR2 Interaction and B Cell Immunity
While C3b opsonization is necessary to amplify complement
activation via the AP, C3b plays a critical role in pathogen
clearance. Erythrocytes bearing CR1 recognize and bind C3b-
opsonized pathogens, and mediate transport of these complexes
to the liver and spleen for clearance (Merle et al., 2015b).
Transport may also be mediated by glycoprotein Ib (GPIb) on
platelets, which captures C3b-opsonized pathogens and enhances
adaptive immune responses via sDCs (Broadley et al., 2016).
In the liver, the opsonized pathogens are carried to specialized
Kupffer cells bearing CRIg, which can also bind C3b and mediate
phagocytosis (Helmy et al., 2006). In the spleen, pathogens are
transported to lymphoid follicles, which are protected by resident
macrophages and DCs in the subcapsular sinus. Meanwhile,
erythrocyte CR1, in the presence of FI, mediates cleavage of C3b
to iC3b and/or C3d, which is recognized by CR2 and CR3. The
subcapsular sinus macrophages and DCs can bind and internalize
complement-tagged antigens and intact target cells, respectively,
Frontiers in Microbiology | www.frontiersin.org 3 January 2017 | Volume 8 | Article 89
fmicb-08-00089 January 28, 2017 Time: 19:8 # 4
Bennett et al. Complement-Mediated Adaptive Immune Evasion
via CR3, and translocate them to naïve B cells or FDCs expressing
CR2 in the lymphoid follicle (Merle et al., 2015b) (Figure 2A).
Within the lymphoid follicle, C3d mediates several functions
that are critical mediators of B cell immunity, which have
been reviewed previously in great detail (Carroll, 2004; Rickert,
2005; Bergmann-Leitner et al., 2006; Toapanta and Ross, 2006;
Carroll and Isenman, 2012) (Figures 2A,B). Indeed, the roles
of complement in the humoral antibody response have long
been established. The first role involves acting as molecular
adjuvant, effectively lowering the threshold for B cell activation
(Carter et al., 1988) (Figure 2B). Crucial to C3d’s function
in B cell mediated antibody response is its association with
CR2. CR2 is part of the B cell co-receptor complex, together
with CD19, CD81, and Leu13 (Matsumoto et al., 1991). Upon
simultaneous engagement of both the BCR and the B cell co-
receptor complex, the antigen threshold for B cell activation
is reduced by up to four orders of magnitude (Carter and
Fearon, 1992; Dempsey et al., 1996). In addition, BCR and B
cell coreceptor crosslinking also enhances antigen processing
and presentation to T cells (Cherukuri et al., 2001). Thus,
C3d is especially critical for B cell stimulation in conditions
where antigen concentration is low, as is typically the case
during pathogen clearance (Carroll and Isenman, 2012). In
addition to C3d’s direct role on B cells, it has been found
that C3d-tagged immune complexes interact with FDCs to
promote a more potent humoral response. Expression of
CR1 and CR2 on FDCs promotes antigen reservoirs through
binding and sequestering C3d-coated immune complexes in
lymphoid follicles (Fischer, 1998). These immune complexes
are cycled through non-degradative endosomal compartments
within FDCs, which preserve the antigen for long periods of time
(Heesters et al., 2013). These events promote the development
of GCs, which is critical for maintenance of memory B cell
repertoires (Fischer, 1998). Finally, C3d opsonization promotes
extended half-life of antigens in blood, further facilitating
generation of adaptive immune responses (Bergmann-Leitner
et al., 2006).
Another mechanism of B cell regulation is mediated by
C4BP. This regulator attaches to negatively charged moieties,
including phospholipids of host membranes and other structures
on bacterial surfaces (Blom et al., 2004). Beyond its complement
inhibitory function, C4BP has been identified to specifically
bind CD40, which is crucial for B cell activation and function.
CD40, upon engagement with its nascent ligand CD40L, induces
B cell proliferation, rescue of GC B cells from apoptosis, and
CSR. Brodeur et al. (2003) found that C4BP by binding to
CD40 could drive B cell activation, similar to what is seen
by canonical CD40-CD40L interaction. A more recent study
suggested that C4BP could also form a stable complex with
soluble CD40L, and this complex upon association to CD40
provided signals that promoted cell survival without influencing
proliferation (Williams et al., 2007). Unfortunately, the effect of
this newly identified C4BP/CD40L complex was only observed
for epithelial cell survival. Thus, future examination of these
associations is required to fully elucidate the effects that C4BP
has on lymphocyte biology and the adaptive immune response.
Intrinsic T Cell Regulation by
Complement
As a doctrine, complement has long been thought as a serum
restricted system and its over 30 proteins could only be
synthesized by the liver; however, this view is rapidly changing.
It has now been identified that many disparate locations, and
tissues in body have local sources of complement (for more detail
discussion see, Kolev et al., 2014). Moreover, almost all cell types
in the human body can produce complement proteins and many
of those even contain intracellular complement stores (Liszewski
et al., 2013).
Interestingly, both locally synthesized and intracellular
complement have proven to be important for CD4+ T cell
survival, proliferation, and differentiation (Heeger et al., 2005;
Strainic et al., 2008; Liszewski et al., 2013; Kolev et al., 2015;
Arbore et al., 2016). It was first identified by Heeger et al. (2005)
that both naïve CD4+ T cells, as well as their cognate APC
partner, could locally synthesize AP complement components
C3, FB, and FD, and later it was shown C5 was also synthesized
(Strainic et al., 2008). Local synthesis of these proteins was
associated with a decrease in CD55, further enhancing AP
activation (Heeger et al., 2005; Strainic et al., 2008). Interestingly,
both the AT receptors C3aR and C5aR were found to be
upregulated on both the T cell and APC during costimulation.
Additionally, C3aR/C5aR activation on T cells provided signals
to both induce IL-12 receptor expression and produce cytokines
IL-12 and IFN-γ (Strainic et al., 2008) (Figure 2C). Given that
IFN-γ supports the lineage commitment of naïve T cells to T
helper 1 cells (Th1), this suggests that autocrine AT receptors
are important in this process. In line with this notion, it was
found that in the absence of autocrine T cell C3aR/C5aR signaling
resulted in CD4+ T cells to commit to a Foxp3+ inducible
regulatory T cell lineage (iTreg) (Strainic et al., 2012) (Figure 2C).
Excitingly, a new study linking autocrine AT receptor T cell
signaling to another innate immune pathway was published. This
study highlighted the role of C5aR in NLRP3 inflammasome
activation, and found that these associations were tied to Th1
induction (Arbore et al., 2016) (Figure 2C). Upon TCR ligation
and CD46 costimulation, intracellular C5 was cleaved and C5aR1
provided signals to drive NLRP3 inflammasome activation, which
resulted in Th1 induction (Arbore et al., 2016). Surface-restricted
C5aR2 was found to be a negative regulator of this process,
promoting a regulatory T cell phenotype (Figure 2C). Thus, this
study further strengthens the notion that autocrine C3aR/C5aR
signaling is vital in skewing T cell differentiation and lineage
commitment.
Many subsequent studies have further strengthened the role of
complement on T cell survival, proliferation and differentiation.
One study highlighted the potential importance of CD46 CTY-1
isoform in T cell regulation (Figure 2C). Coengagement of both
TCR and CD46 in the presence of increasing IL-2 concentration
induces IL-10 producing regulatory T cells (Cardone et al., 2010).
Another recent study showed that intracellular C3 was cleaved
into biologically active C3a and C3b by intracellularly expressed
protease CTSL (Liszewski et al., 2013) (Figure 2C). Together
these studies highlight the crucial role that local and intracellular
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FIGURE 2 | Crosstalk between complement and adaptive immunity. (A) Depicts the entry of C3d-coated immune complexes into the lymph nodes via the
afferent venule. These complexes will associate with CR3 on subcapsular macrophages. These complexes will move from the apical side to basolateral where the
immune complex is transferred to CR2 on the surface of naïve B cells within the GC, and handed off to FDCs. In the final stages, this complex is then presented to
affinity matured GC B cells for T cell dependent responses. (B) Highlights the molecular adjuvant affect of C3d. In low antigen conditions, antigen engagement of
BCR alone is not sufficient to promote associated Igα/β signaling and B cell activation. Antigen-bound C3d will bind CR2, part of the B cell co-receptor complex
(together with CD19 and CD81), and coligation of BCR and the B cell co-receptor complex amplifies the molecular signal that leads to downstream B cell activation.
(C) Illustrates the role of locally and intracellularly synthesized complement components on T cell homeostasis and priming. Intracellular C3 is cleaved by CTSL into
biologically active C3a and C3b. Intracellular C3a/C3aR association is important for T cell survival. Extracellular C3a/C3aR and C5a/C5aR association influence Th1
lineage commitment, and in their absence, can lead to iTreg induction. The extracellular association of C3b with its receptor CD46 on T cells influences the metabolic
state of the T cell, shifting it from a metabolically quiescent state to an active state (through increased GLUT1, LAT1, and LAMTOR expression). Costimulation of
CD46 upon activation of TCR influences the expression of NLRP3 and results in cleavage of intracellular C5. Extracellular C5aR2 activation provides signals that
inhibit the activation of the NLRP3 inflammasome leading to increased IL-10 production and Th1 contraction. Paradoxically, intracellular C5aR1, upon activation,
leads to activation of the inflammasome resulting in Th1 induction. (D) Highlights the role of complement in activation of APCs and their crosstalk with T cells.
Activation of extracellular C3a/C3aR and C5a/C5aR results in the activation of the APC. APC generated C3a and C5a can bind to the AT receptors on T cells to
induce a Th1 response. Absence of C5aR on DCs leads to the induction of Th17 and Tregs. Extracellular stimulation of APCs, primarily DCs, with complement
soluble regulators C4BP and FH leads to a tolerogenic state of the DCs and results in the induction of Tregs. Crosstalk between C5aR and TLR2/4 or CR3 and
TLR2/4 on APC surface results in diminished IL-12 production and downstream Th1 response. Finally, C1q and its receptors are crucial for the silent removal of
apoptotic cells (i.e., provides pro-efferocytic signals) and this can influence T cell response.
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complement plays in T cell biology, and opens the possibility that
local complement is differentially regulated compared to serum
complement.
Recently, studies have begun to unravel more unexpected
roles for complement in driving fundamental T cell processes.
Before activation, naïve CD4+ T cells are metabolically
quiescent. Important for expansion and differentiation, these
naïve cells must undergo major reprogramming such that
they increase their nutrient uptake and usage of metabolic
pathways. Interestingly, autocrine C3b stimulation of CD46, and
specifically its intracellular domain CTY-1, was important for this
metabolic change and for production of the proinflammatory
cytokines needed for Th1 differentiation (Kolev et al., 2015)
(Figure 2C). This study speaks to the fundamental nature that
local complement plays on T cell biology. Remarkably, and in line
with this notion, Notch family member Jagged1 was identified as
the third physiologically relevant ligand for CD46 (Le Friec et al.,
2012). The authors proposed that CD46 could sequester Jagged1
away from Notch to induce IFN-γ secreting Th1 cells. Altogether
these aforementioned studies indicate that CRs (C3aR/C5aR,
CD46) and their ligands are crucial regulatory components of T
cell lineage commitment and survival.
APC-Mediated Regulation (Paracrine)
Complement also plays an important role at the immunological
synapse between APCs and T cells (Figure 2D). APCs (i.e., DCs)
have been shown to express many of the same complement
components as T cells, which also function in a similar fashion
(Peng et al., 2008; Li et al., 2012). Extracellularly generated
C3a/C5a was linked to increased expression of C3aR/C5aR
on DCs, which increased both their activation [apparent by
increased expression of costimulatory molecules (CD86 and
MHCII)] as well as their costimulatory capacity (increased Th1
cytokine production) (Strainic et al., 2008; Li et al., 2012).
Interestingly, blockade of the C3aR/C5aR signaling axis on DCs,
such that extracellularly generated C3a/C5a could no longer
bind, resulted in diminished costimulation capacity, apparent
by a decrease in IFN-γ producing cells (Strainic et al., 2008).
Independently, it was observed that using C5aR1 deficient DCs,
but not C5L2, supported the induction of both Treg and Th17
lineages (Figure 2D). As in T cells, the two C5aR receptors
and potentially C3aR seem to have independent roles in DCs
(Weaver et al., 2010). These studies suggest that local complement
generation by DCs provides important paracrine effects for T cell
stimulation.
Beyond the AT receptor signaling axis, other complement
regulators have also been shown to be important for DC
differentiation/activation and downstream T cell response.
Complement activation is under tight control by both membrane
bound (CD46, CD55) and soluble (C4BP, FH) regulators. Two
independent studies found that both FH and C4BP [β-chain
lacking isoform(β-)] influence the early stages of monocyte
to DC differentiation, and promote a tolerogenic/immature
and anti-inflammatory DC phenotype (Olivar et al., 2013,
2016). Moreover, these DCs exhibited decreased production of
proinflammatory Th1 cytokines, and increased production of
IL-10 and TGF-β cytokines indicative of an anti-inflammatory
response. Not so surprisingly, this resulted in impaired T
cell proliferation and Th1 polarization, and instead induced
a Foxp3+ Treg response (Olivar et al., 2016) (Figure 2D).
Together, these studies suggest a non-redundant role of
complement on DC differentiation and downstream T cell
response, and that perhaps AP is not the only complement
pathway governing T cell/DC differentiation and APC-T cell
costimulation. To add to this notion, C1q has been found
to have a unique function in antigen presentation and T cell
priming. It is well-established that phagocytes not only internalize
pathogens, but also ingest apoptotic host cells, a process that has
been termed efferocytosis, both of which are influential on the
cytokine response. Many studies have identified that C1q directly
associates with both apoptotic DCs and macrophages (referred
to C1q-polarized APCs) (Figure 2D). This association leads
to increased efferocytosis and suppression of proinflammatory
cytokine production (Korb and Ahearn, 1997; Baruah et al., 2009;
Teh et al., 2011; Clarke et al., 2015). These dynamics led to
suppressed Th1 and Th17 cell proliferation. These studies suggest
a unique function of CP component C1q on APC and T cell
costimulation, further supporting the notion that complement
is truly a bridge between the adaptive and innate immune
response.
Other Mechanisms
C1q Receptors gC1qR and cC1qR Mediate APC and
T Cell Stimulation
C1q is central to the activation of the CP of complement, and
as aforementioned has unique function on modulating APC-
driven cytokine production and downstream T cell priming.
Structurally, individual C1q molecules are composed of a
globular head situated on the carboxy termini of the collagen
stock domain, and these molecules subsequently multimerize
to form the prototypical hexameric “bouquet” superstructure
(Sontheimer et al., 2005). Paradoxically, the functional relevance
of the two co-expressed non-transmembrane cell surface
associated receptors, gC1qR (interacts with globular head of
C1q) and cC1qR (interacts with collagen stock of C1q), is still
ambiguous (Frachet et al., 2015). However, while their exact
function still remains controversial, studies suggest they may
play a vital role in the adaptive immune response. We will
now highlight our current understanding of these receptors and
the potential role they play in driving the adaptive immune
response.
C1q, as previously mentioned, is a crucial driver of pro-
efferocytic signals and downstream T cell priming, although
controversy still surrounds which of the C1qRs is important
for this function (Nayak et al., 2012; Frachet et al., 2015). The
prevailing hypothesis is that a tripartite interaction between
C1q, gC1qR and cC1qR on apoptotic cells, and bystander
phagocyte respectively, induces efferocytosis (Hosszu et al., 2012;
Frachet et al., 2015) (Figure 2D). Recently it was shown that
gC1qR, which is present on both immature DCs and blood
precursor DCs, interacts with DC-SIGN (Hosszu et al., 2012).
As both C1qRs lack transmembrane domains and cannot signal
on their own and must recruit signaling partners, DC-SIGN
Frontiers in Microbiology | www.frontiersin.org 6 January 2017 | Volume 8 | Article 89
fmicb-08-00089 January 28, 2017 Time: 19:8 # 7
Bennett et al. Complement-Mediated Adaptive Immune Evasion
is now postulated to be a transmembrane signaling partner
of gC1qR. Interestingly, authors suggested that DC-SIGN also
directly interacts with C1q, and given C1q’s role on DC
differentiation, postulated that perhaps this trimolecular receptor
complex between C1q-gC1qR-DC-SIGN might also influence
DC differentiation (Hosszu et al., 2012). Additionally, gC1qR
can also directly influence cytokine response. Crosstalk between
gC1qR and TLR4 resulted in a dampened IL-12 response, a
cytokine important for IFN-γ production and subsequently Th1
cell proliferation and differentiation (Waggoner et al., 2005).
Furthermore, C1q can directly bind to T cells via C1qRs and
induce anti-proliferative effects (Chen et al., 1994). It has been
suggested that gC1qR is pivotal in the regulation of the antiviral
T cell response. Another study found that both of the C1qR’s
offered a unique function on the differentiation process from
monocytes to DCs. Immature monocytes were found to have high
levels of gC1qR and low levels of cC1qR, a phenotype that was
reversed as the cells began to differentiation to a DC lineage.
The authors theorized that C1q/C1qR system was crucial for
the regulation and transition from innate monocyte state to that
of a professional APC (Hosszu et al., 2010). Thus, we are still
trying to understand the role that gC1qR plays in driving acquired
immunity.
Crosstalk between Complement and Toll-Like
Receptors
Toll-like receptors and CRs are both critical to the innate
immune response and are co-expressed on leukocytes. Thus,
it is not surprising that crosstalk between these classes of
receptors has been demonstrated. Recent evidence supports a role
of CR-TLR crosstalk in instructing adaptive immune response
(Hajishengallis and Lambris, 2010, 2016). Mechanistically, this
crosstalk has largely been observed to be at the MAPK level,
specifically through the ERK1/ERK2 pathway (Hajishengallis and
Lambris, 2010).
It is becoming increasingly clear that the AT receptors have
a multifaceted role in guiding the host immune response,
that reaches beyond its canonical function in complement.
As mentioned above, these receptors are crucial in antigen
presentation and T cell survival/response. Interestingly, the AT
receptors have also been found to influence TLR driven cytokine
production and downstream T cell responses. In particular, C5aR,
depending on the immunological cell, has been shown to have
paradoxical function on TLR cytokine response. On DCs, it
was identified that C5aR-TLR2 crosstalk could synergistically
enhance TLR driven IL-12 production, which resulted in an
increased Th1 response (Weaver et al., 2010). Conversely, other
studies have provided evidence that C5aR-TLR2 and C5aR-
TLR4 crosstalk on macrophages inhibit IL-12 family of cytokine,
specifically IL-12p70, thereby diminishing the Th1 response
(Figure 2D). Thus, the immunological consequence of AT
receptor-TLR crosstalk seems largely dependent on the type of
APC.
Crosstalk between CR3 and TLRs has also been identified,
which also has an influence on TLR cytokine response and quality
of the adaptive immune response. Much like what was seen
with C5aR, CR3 when co-activated with either TLR2 or 4, leads
to suppressed IL-12 (IL-12p70) expression and accordingly a
diminished Th1 response (Figure 2D). However unlike C5aR,
TLRs are able to activate CR3 through a cellular process that
has been termed “inside-out” signaling. Although using slightly
different pathways, this has been verified for both TLR2-CR3
and TLR4-CR3 activation. CR3-TLR2 activation seems to be
dependent on PI3K, meanwhile TLR4-driven CR3 activation is
driven by MyD88. Engagement of CR3 alone by iC3b-coated
cells has also been shown to downregulate IL-12 production
(Marth and Kelsall, 1997). Additionally, gC1qR-TLR crosstalk has
also been demonstrated but has redundant effects to C5aR/CR3-
TLR2, -TLR4 on IL-12 expression. Taken together, these findings
suggest yet another strong tie between complement and adaptive
immunity.
COMPLEMENT EVASION BY
PATHOGENS
While complement offers a potent immunological barrier,
pathogenic organisms have developed counterstrategies to elude
harmful responses. Pathogenic complement evasion has been
extensively studied, and countless mechanisms and examples are
described in literature (reviewed in Lambris et al., 2008; Stoermer
and Morrison, 2011; Ricklin, 2012; Zipfel et al., 2013; Merle
et al., 2015b; Garcia et al., 2016). These mechanisms include
secretion of complement inhibitory molecules, recruitment
of host complement regulators, and proteolytic cleavage of
complement effector molecules. Most examples of complement
evasion have been studied in the context of innate immune
blockade, however given the close ties between complement
and adaptive immunity, it is likely that these mechanisms also
modulate B and T cell responses. In the remainder of this
review, we highlight specific examples of pathogenic evasion of
complement-mediated adaptive immunity (Table 1; Figure 1).
Based on these examples, we also postulate possible new roles for
known evasion molecules.
Blocking B Cell Immunity
C3d is the smallest of the C3 fragments that opsonizes antigens
and target cells, and plays a number of critical roles in
directing adaptive immunity, as described above. Interestingly,
C3d is a “molecular hub” of sorts, binding not only host
complement regulators and receptors, but also a multitude of
immune evasion molecules. While many of these molecules
have been studied extensively, most work focuses on their
role in inhibition of C3 and C5 cleavage, and resulting direct
complement inhibitory functions. However, some studies show
that blockade of C3d can lead to impaired adaptive immune
responses.
Staphylococcus aureus is a Gram-positive bacterium that
colonizes a large proportion of the human population. However,
this bacterium can also become pathogenic, and is responsible
for severe infections. S. aureus is considered a master of
immune evasion. Indeed, tens of virulence factors have
been identified, which influence innate immunity through
inhibition of neutrophil chemotaxis and intracellular killing
Frontiers in Microbiology | www.frontiersin.org 7 January 2017 | Volume 8 | Article 89
fmicb-08-00089 January 28, 2017 Time: 19:8 # 8
Bennett et al. Complement-Mediated Adaptive Immune Evasion
TABLE 1 | Mechanisms for pathogenic evasion and modulation of complement-mediated adaptive immunity.
Organism Evasion molecule Mechanism Function(s)
Blocking B cell immunity
S. aureus Efb, Ecb, Sbi Binds C3d, inhibits CR2 binding Inhibits B cell stimulation
P. berghei CSP Binds C3d, likely inhibits CR2 binding Prevents antibody production
C. albicans MP60 Binds C3d Enhances cell adherence
HSV-1 gC-1 Binds C3b, prevents complement activation Reduces viral antibody titers (C3 and CR1/2
necessary for adaptive response)
HCV NS5A, HCV core Inhibits C3 and C4 mRNA transcription,
upregulates CD55
Inhibits binding to B cells (C3 and CR1/2 necessary
for adaptive response)
HIV gp41 Binds FH, enhances surface iC3b/C3d
deposition, attaches to CR2-bearing cells
Generates viral reservoirs, enhances cell infectivity
S. aureus SCIN Binds C3b, inhibits CR1 and CRIg binding May block CR1-mediated trafficking and B cell
binding/stimulation1
Blocking direct T cell regulation
HCV HCV core Binds gC1qR (on T cells) Decreases IL-2 and IFN-γ, inhibits Th1 and
promotes Th2 response
HIV gp41 Binds gC1qR (on T cells) Induces NKp44L expression, facilitates
NK-mediated killing of uninfected T cells
S. pyogenes M1 Binds CD46 (on T cells) Induces IL-10 secreting Tregs
Measles virus Hemagglutinin Binds CD46 (on monocytes and DCs) Inhibits IL-12 production, enhances IL-10
production, but may enhance inflammatory
response (in some cases)
M. leprae PGL-1 Binds C3, mediates binding to CD46
(on T cells)
Induces IL-10 secreting Tregs
S. aureus SpA Binds gC1qR May inhibit Th1 and promote Th2 response1
L. monocytogenes InlB Binds gC1qR May inhibit Th1 and promote Th2 response1
Blocking indirect T cell regulation
P. gingivalis HRgpA, RgpB Cleaves C5, C5a binds C5aR (on
macrophages)
Manipulates C5aR-TLR2 crosstalk, inhibits IL-12
and IFN-γ production, inhibits Th1 response
P. gingivalis Fimbrae proteins Binds CR3 Manipulates CR3-TLR2 crosstalk, inhibits IL-12
production, enhances pathogen clearance
L. major gp63 Cleaves C3b to iC3b, facilitates CR3
binding
Inhibits IL-12 production, enhances IL-10
production
B. anthracis BclA Binds CD14 and CR3 Manipulates CR3-TLR2 crosstalk for cell entry
F. tularensis ? Binds CR3 Inhibits TLR2-mediated proinflammatory cytokine
production
B. pertussis FHA Binds CR3 Inhibits IL-12 production
HIV gp41 Binds FH and enhances surface iC3b, or
can bind CR3 directly
Manipulates CR3/TLR8 crosstalk, inhibits antiviral
and proinflammatory responses
S. aureus CHIPS Binds and inhibits C5aR May manipulate C5aR-TLR2 crosstalk, inhibit IL-12
production and Th1 response1
Other inhibition mechanisms
Vaccinia virus VCP Cleaves C3b to iC3b Inhibits CD4+ and CD8+ T cell response
(dependent on C3)
WNV NS1 Binds FH, mediates C3b cleavage
Binds C4BP, mediates C4b cleavage
Binds C1s to cleave C4
Inhibits CD4+ and CD8+ T cell response (C3 and
CR1/2 necessary for adaptive response)
1The functional outcome of these evasion mechanisms has not been definitively shown, but is postulated based on the results from other known mechanisms.
mechanisms, phagocytosis, complement, TLR signaling, and
also by directly killing host cells. S. aureus also modulates
adaptive immune responses directly, using superantigens that
crosslink TCRs and MHCII molecules and hyperactivate T
cell responses (Thammavongsa et al., 2015; Koymans et al.,
2016). In particular, complement evasion is arguably best
understood in the case of S. aureus, in which numerous evasion
molecules exert control over several points in the complement
cascade. Despite their well-characterized roles in complement
evasion, it remains unclear whether most of these molecules
influence complement-mediated adaptive immunity. Notably,
two homologous virulence factors from S. aureus, Efb-C and Ecb
(also known as Ehp) influence B cell immunity. Initially, these
molecules were described to bind nearly all thioester-containing
C3 proteins and inhibit the complement AP (Lee et al., 2004;
Hammel et al., 2007a,b; Jongerius et al., 2007). A follow-up study
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demonstrated that both proteins can also inhibit the interaction
between C3d and CR2, and prevent B cell stimulation, which may
act as another evasion strategy for S. aureus (Ricklin et al., 2008).
Additionally, there is a case for Sbi having a similar role, as it also
competitively inhibits the C3d-CR2 interaction (Burman et al.,
2008; Isenman et al., 2010).
Other pathogens produce proteins that bind C3d as well.
The CSP from Plasmodium berghei can bind to C3d, preventing
production of antibodies against the antigen and reducing
protective immunity during associated malaria infection
(Bergmann-Leitner et al., 2005). The mechanism of modulating
antibody response was not elucidated, but it is presumed that
CSP also blocks the C3d-CR2 interaction, which interferes
with stimulation of B cells in the lymphoid follicle. Candida
albicans expresses MP60 and mannoproteins that bind C3d and
mediate binding to host cells (López-Ribot et al., 1995; Stringaro
et al., 1998), however, the functional consequences on adaptive
immunity remain unclear.
Some pathogens interfere with complement-mediated B cell
immunity through modulating events in the complement cascade
upstream of C3 deposition. HSV-1 expresses a glycoprotein
(gC-1), which binds to C3b and blocks binding sites for C5
and properdin (Kostavasili et al., 1997). In addition, gC-1 can
mediate decay of C3 convertase enzymes, limiting the amount
of complement opsonization on the viral surface (Fries et al.,
1986). While this protein is described to inhibit complement-
mediated neutralization of HSV-1 (Lubinski et al., 2002), another
study with C3 and CR1/2 deficient mice showed reduced IgG
response to the virus, suggesting that complement is critical in
development of adaptive immune response against HSV-1 (IgG
and GCs) (Da Costa et al., 1999). Thus, gC provides an important
evasion strategy for HSV-1 to escape complement-driven
adaptive immunity. HCV influences complement activation via
distinct mechanisms. The HCV core protein and NS5A target
USF-1 and IRF-1, leading to inhibited mRNA transcription in
infected hepatocytes, and diminished C4 levels in mice (Banerjee
et al., 2011). A follow-up study showed that NS5A also inhibits C3
mRNA transcription. Indeed, human patients with HCV showed
low C3 levels in serum, and biopsies showed lower C3 mRNA
levels in the liver (Mazumdar et al., 2012). Another recent study
showed that HCV core protein induced soluble CD55 expression,
which limits complement activation in infected hepatocytes
(Kwon et al., 2016). Each of these mechanisms can inhibit viral
opsonization and in turn may inhibit complement-mediated B
and T cell responses. Finally, Wang et al. (2016) demonstrated
that HCV binds to B cells via interactions between C3 fragments
and either CR1 or CR2. Thus, by inhibiting opsonization, HCV
could escape recognition by B cells. Another possible mechanism
was proposed for SCIN, which mediates dimerization of C3b
molecules and AP C3 convertases on the bacterial surface. In
doing so, SCIN effectively masks the binding sites for CR1 and
CRIg, preventing phagocytic responses and cleavage of C3b to
iC3b (Jongerius et al., 2010). In turn, SCIN likely inhibits CR-
mediated immune adherence and trafficking, B cell stimulation,
and antigen presentation.
In contrast to C3d-CR2 blockade, viruses can exploit this
interaction to promote their survival and pathogenesis. HIV,
for example, carefully balances complement activation and
regulation in order to capitalize on the links between complement
and B cell immunity. While HIV virions indeed activate
complement (Sullivan et al., 1998), the virus incorporates
membrane-bound complement regulators from the infected host
cell, including CD46, CD55, and CD59 (Montefiori et al., 1994).
Additionally, HIV glycoproteins gp41 and gp120 recruit FH to
the viral surface (Stoiber et al., 1995). These regulators limit
the amount of C3 deposition on the virus and prevent direct
lysis by MAC. During infection, HIV disseminates through
the bloodstream, becomes opsonized with C3b, and encounters
erythrocytes bearing CR1 (Horakova et al., 2004). These
erythrocytes then bind and transport complement-opsonized
virions to secondary lymphoid organs (Schifferli et al., 1988).
Meanwhile, CR1 can also act as a cofactor for FI-mediated
cleavage of C3b to iC3b and eventually C3d, which facilitates
transfer of HIV from erythrocytes to B cells and FDCs bearing
CR2. HIV leverages these interactions to promote maintenance
of extracellular viral reservoirs in the lymphoid follicle, where
virions are captured on CR2-expressing FDCs (Bergmann-
Leitner et al., 2006). Several lines of evidence demonstrate that
intact HIV virions can be maintained for over 6 months in GCs
(Cavert et al., 1997). Although these virions are “trapped” and
opsonized, they still retain infectivity once released (Banki et al.,
2005). Most importantly, the high concentration of HIV in the
lymphoid follicle promotes infection of CD4+ T cells, which is
critical for the pathogenesis of the virus (Stoiber et al., 2008).
Inhibiting T Cell Immunity through CR
Engagement
CRs play a critical role in T cell proliferation and differentiation,
as described in detail above. Thus, many pathogens have also
evolved strategies to engage these receptors in order to modulate
T cell immunity in their favor.
As described above, HCV produces multiple proteins that
modulate levels of complement proteins in infected hepatocytes.
In particular, the HCV core protein inhibits C3 mRNA
transcription, while upregulating soluble CD55 production.
Another important role of HCV core protein includes inhibition
of T cell proliferation through its interaction with gC1qR on DCs,
B cells, and T cells (Kittlesen et al., 2000). Binding of HCV to
gC1qR on activated T cells decreases IL-2 and IFN-γ production
(Yao et al., 2001a). Engagement of gC1qR on DCs inhibited IL-
12 production, and promoted a shift from Th1 to Th2 response
(Waggoner et al., 2007). A later study showed that patients with
chronic HCV infection had persistent elevated levels of gC1qR+
CD4+ T cells, which increased the susceptibility to viral evasion
via HCV core protein (Cummings et al., 2009). Other viruses,
including HIV, EBV, and HSV, are also known to engage gC1qR,
and may induce similar effects on T cell immunity (Yao et al.,
2001b; Fausther-Bovendo et al., 2010). Similarly to HCV, HIV
can also engage gC1qR. HIV expresses glycoprotein gp41 on
its surface, which during fusion with the membrane of infected
CD4+ T cells, can interact with gC1qR on uninfected T cells.
This interaction induces expression of NKp44L, a ligand for
cytotoxicity receptor NKp44 on NK cells. This mechanism causes
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NK cells to selectively deplete uninfected CD4+ T cells during
HIV pathogenesis (Fausther-Bovendo et al., 2010).
Numerous other pathogens produce molecules that bind
gC1qR, which may enable them to subvert undesired T cell
responses. For instance, S. aureus produces SpA, a protein
known to bind many ligands and contributing to the virulence
of numerous strains. Perhaps the most well-known function
involves binding of IgG molecules via their Fc region, in order
to avoid bacterial opsonization and subsequent phagocytosis.
SpA was also reported to bind gC1qR on platelets, and while
the exact physiological role of this interaction is unclear, it
may be involved in adherence of S. aureus to sites of vascular
injury (Nguyen et al., 2000). Based on the aforementioned
evasion mechanisms, it is plausible that S. aureus uses SpA
to bind gC1qR on T cells, in order to downregulate IL-12
and prevent Th1 response. In addition, Listeria monocytogenes,
another infectious bacterium, expresses another gC1qR-binding
protein called InlB. The bacterium utilizes InlB to enter gC1qR-
expressing mammalian cells, facilitating intracellular uptake and
survival of the bacterium. InlB may allow specific entry of
L. monocytogenes into CD4+ T cells expressing gC1qR as well,
simultaneously escaping aggressive Th1 response (Braun et al.,
2000).
Aside from gC1qR, CD46 is another CR present on T
cells, which plays an important role in modulating T cell
response. Group A Streptococcus (Streptococcus pyogenes), a
Gram-positive bacterial pathogen, comprises numerous immune
evasion mechanisms, similarly to S. aureus. S. pyogenes strains
are characterized by the expression of distinct M proteins that
protrude from and mask the bacterial surface. Different M
serotypes bind a wide variety of host proteins and confer bacterial
resistance to immune responses. A recent study showed that
several M serotypes can bind directly to CD46 on humans CD4+
T cells, resulting in the induction of IL-10 secreting regulatory T
cells upon costimulation with an anti-CD3 antibody. These data
suggest that M protein, by exploiting the immunomodulatory
function of CD46, could delay effector T cell response and
allow S. pyogenes to further establish infection (Price et al.,
2005). Several additional bacteria and viruses, including Measles
virus, HHV-6, Escherichia coli, and Neisseria bind CD46 and
influence cytokine profiles of APCs and T cells, but it remains
unclear whether these pathogens engage and modulate T cells
directly (Cattaneo, 2004; Kemper and Atkinson, 2009). Measles
virus hemagglutinin is known to bind CD46, which results in
IL-12 downregulation in primary monocytes and DCs (Karp
et al., 1996; Marie et al., 2001). In a later study, transgenic
mice expressing either of the two human CD46 molecules
(with differing cytoplasmic tails) were injected with vesicular
stomatitis virus expressing measles virus hemagglutinin. Mice
expressing CD46-1 showed enhanced IL-10 production and
immunosuppressive response, while those expressing CD46-2
exhibited enhanced inflammatory response (Marie et al., 2002).
These results are further complicated with the observation that
Measles virus downregulates CD46 on T cells in vivo, and
preferentially engages an alternate receptor (Yanagi et al., 2006).
Thus, the role of CD46 in Measles virus pathogenesis remains
somewhat unclear.
Mycobacterium leprae, the pathogen responsible for causing
leprosy, engages CD46 using a slightly different mechanism. It
has long been known that M. leprae negatively affected DC
maturation and downstream T cell response, but how this
occurred remained elusive due to lack of appropriate models.
However, using non-virulent M. bovis BCG, it was identified that
PGL-1, which had been suspected to influence the pathogenesis
of M. leprae, was the culprit. In fact, PGL-1 was able to exploit
CR3 to allow entry of BCG into DCs, which subsequently led
to dampened DC maturation (Tabouret et al., 2010). A parallel
study found that PGL-1 was exposed on surface of infected
DCs and lipid rafts of T cells, where it was able to bind C3.
Interestingly, CD46 on T cells was able to recognize this C3-
PGL-1 complex on M. leprae infected human DCs resulting
in the differentiation of IL-10 producing Tregs (Callegaro-
Filho et al., 2010). Together these studies provide evidence
that mycobacterium, by associating with various complement
components, can directly affect the outcome of the adaptive
immune response. In addition, a new study, found that FH
plays a defining role in the internalization process of M. bovis
BCG in macrophages. The authors found that FH, by directly
binding to the M. bovis BCG, could affect the uptake of M. bovis
BCG and thereby alter the cytokine response. While it remains
unclear FH binding might affect the outcome of the adaptive
immune response, it is clear mycobacterium affects multiple parts
of the complement cascade, leading to altered T cell response
(Abdul-Aziz et al., 2016).
In addition to the mechanisms outlined, CD46-mediated
T cell regulation could be a general evasion mechanism for
pathogens. Upon complement activation, pathogens become
opsonized by C3b, which can bind CD46 on T cells. In
combination with CD3 costimulation, this event could help drive
IL-10 induction and regulatory T cell response against these
microbes. Furthermore, complement-opsonized pathogens that
are internalized by T cells could achieve a similar response by
engaging intracellular CD46.
Indirectly Modulating T Cell Immunity via
APCs
In the last decade, numerous links between complement
activation and TLR signaling have been uncovered, which can
drive adaptive immune responses (Hajishengallis and Lambris,
2010). Likewise, pathogens have developed strategies to evade
these immune mechanisms (Hajishengallis and Lambris, 2011).
Porphyromonas gingivalis is a Gram-negative bacterium that
is known to cause dysbiosis within the periodontal microbiome.
This bacterium is a prime example of how exploitation of
CR-TLR crosstalk can direct adaptive immunity. P. gingivalis
produces two enzymes, HRgpA and RgpB, which directly cleave
C5 into C5a and C5b. The resulting C5a can then engage C5aR1,
while bacterium simultaneously binds TLR2 (Wang et al., 2010),
and the C5aR1-TLR2 crosstalk can influence cytokine profiles
through different signaling cascades. Interestingly, the functional
role of these interactions is entirely different depending
on the cell type involved. In macrophages, C5aR1-TLR2
crosstalk can selectively inhibit IL-12 and IFN-γ production,
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through induction of PI3K and ERK1/2 signaling. This evasion
mechanism allows the pathogen to induce a customized
adaptive immune response, preventing Th1 induction (Liang
et al., 2011). At the same time, this signaling leads to
increased cAMP production and leads to downregulation of
antimicrobial nitric oxide production. However, in neutrophils,
C5aR1-TLR2 signaling mediates proteosomal degradation of
MyD88 and activation of an alternate signaling pathway, which
inhibits phagocytosis, but maintains inflammatory responses
to propagate periodontal dysbiosis (Maekawa et al., 2014). In
contrast, C5aR1 signaling mediates bacterial killing in DCs.
This evidence indicates that the pathogen has tailored leukocyte
evasion to its environment, where it primarily encounters
neutrophils and macrophages, but not DCs (Hajishengallis
and Lambris, 2016). The mechanisms underlying the variable
signaling are still unclear.
Porphyromonas gingivalis also utilizes an additional
mechanism to influence IL-12 production via CR-TLR crosstalk.
The fimbrial proteins, expressed on the bacterial surface, engage
CR3 and mediate internalization and intracellular survival
within macrophages, as well as reduced IL-12 production.
This mechanism was shown to be dependent on TLR2, which
also binds fimbrial proteins and induces inside-out signaling
that activates CR3 (Wang et al., 2007). Experiments in mice
showed that blockade of CR3 restored IL-12-mediated pathogen
clearance, thus demonstrating that this immune mechanism also
promotes pathogen survival and escape of adaptive immune
response (Hajishengallis et al., 2007).
In addition, numerous other pathogens can bind both CRs
and TLRs to infect host cells, inhibit IL-12 production, and
direct T cell immunity (Hajishengallis and Lambris, 2011, 2016).
Bacillus anthracis spores infect professional phagocytes in their
host to promote their growth and survival. The outer layer of
B. anthracis spores contain a glycoprotein, BclA, which mediates
cell internalization via CR3 (Oliva et al., 2008). Since CR3
must be activated in order to facilitate internalization, it was
unclear how BclA leveraged this receptor to invade host cells.
Interestingly, a subsequent study found that BclA also binds
CD14, which induces TLR2-mediated inside-out signaling to
activate CR3 and internalize B. anthracis spores (Oliva et al.,
2009). Francisella tularensis strain Schu S4 also subverts immune
response via CR3 and TLR2. C3-opsonized F. tularensis is
internalized by macrophages via CR3, and through outside-in
signaling mechanisms, blocks TLR2-mediated proinflammatory
cytokine production (Dai et al., 2013). Bordetella pertussis
FHA inhibits IL-12 production and binds CR3, but it remains
unclear whether these events are connected (Ishibashi et al.,
1994; McGuirk and Mills, 2000). Another interesting CR-TLR
evasion mechanism was recently uncovered for HIV, in which
the complement-opsonized virus engages both CR3 and TLR8
outside and within DCs, respectively. The CR3-TLR8 signaling
crosstalk led to reduced antiviral and inflammatory cascades,
while promoting viral transcription and replication (Ellegård
et al., 2014). Whether or not these CR-TLR crosstalk events direct
T cell responses requires further investigation.
It is possible that coengagement of CRs and TLRs represents
a general strategy of immune modulation, since most opsonized
microbes are likely to engage both simultaneously. The question
remains as to whether these events trigger pathways involved
in clearance or killing, or whether they promote pathogenic
survival. In the case of P. gingivalis, for example, C5aR1-
TLR2 coengagement can induce many different immunological
outcomes depending on cell type. Thus, further investigation of
these signaling mechanisms may be critical for understanding
how pathogens exploit CR-TLR crosstalk. One related evasion
strategy was recently proposed for S. aureus. As described above,
activation of both TLR2 and C5aR1 drives Th1 response in
splenic DCs. S. aureus expresses both TLR2 inhibitors (i.e.,
SSL3) and C5a inhibitors (i.e., CHIPS), which can inhibit C5aR
signaling in sDCs, and thereby shift T cell response toward Th17
(Weaver et al., 2010).
It has also been established that microbes use CR3 to promote
immunologically silent entry into host cells (Marth and Kelsall,
1997). Many pathogens cleave C3b to iC3b on their surface, which
promotes binding to CR3. This is achieved through recruitment
of host complement regulators, host proteases, or secretion
of endogenously expressed proteases (Potempa and Potempa,
2012). Some strains of the eukaryotic parasite Leishmania
produce a glycoprotein (gp63) on the surface of the parasite that
can cleave C3b into inactive form iC3b, resulting in the inhibition
of convertase formation and terminal complement activation
(Brittingham et al., 1995). Allowing iC3b to associate with CR3
on APCs inhibits IL-12 production (Marth and Kelsall, 1997),
and although not directly shown, results in altered T cell response
(Da Silva et al., 1989). As described above, HIV also exploits
CR3 to infect immune cells while avoiding harmful inflammatory
cascades. In order to improve its chances at CR3 recognition,
HIV glycoproteins gp120 and gp41 can recruit FH and mediate
C3b breakdown to iC3b, and gp41 may even engage CR3 directly
(Stoiber et al., 1995).
Other Mechanisms of Complement
Inhibition
There are several examples in which pathogens inhibit
complement activation and influence T cell immunity, through
mechanisms that are not fully understood. Poxviruses are a
large family of viruses (69 members) including smallpox virus
and vaccinia virus, which employ novel strategies to evade
complement-mediated recognition and clearance. These viruses
express complement regulator mimics, which are comprised
of up to four CCP domains. These proteins bind C3b and C4b
in a similar manner to host complement regulatory proteins,
promoting convertase decay and opsonin cleavage (Ojha et al.,
2014). VCP from vaccinia virus is one example that, in addition
to its direct complement regulatory role, can inhibit CD4+
and CD8+ T cell responses. In an intradermal infection model,
mice infected with a VCP-knockout strain of vaccinia virus
had increased numbers of CD4+ and CD8+ T cells at the site
of infection, and exhibited increased T-dependent antibody
response, compared to infection with the wild-type virus.
Interestingly, no difference in T cell responses was observed
in C3−/− mice, indicating that the role of VCP in inhibition
of T cell responses is complement dependent. The authors of
Frontiers in Microbiology | www.frontiersin.org 11 January 2017 | Volume 8 | Article 89
fmicb-08-00089 January 28, 2017 Time: 19:8 # 12
Bennett et al. Complement-Mediated Adaptive Immune Evasion
this study suggest that functionally homologous molecules from
other poxviruses may play a similar role in viral evasion of T cell
immunity (Girgis et al., 2011).
Poxviruses are not the only family of virus that evades
complement mediated adaptive response; flaviviruses do as well.
Flaviviruses are positive stranded RNA viruses, and include
viruses that to this day can be deadly, such as dengue virus.
One strong example of the mechanisms used by flavivirues to
evade the host immune defense comes from WNV. Adaptive
immune response against WNV is dependent on all three
complement pathways. In particular, the AP drives CD4+ and
CD8+ T cell responses directly, without affecting antibody titers,
as demonstrated by FB−/− mice (Mehlhop and Diamond, 2006).
NS1 from WNV, in similarity to NS1 from other flaviviruses,
binds FH and facilitates FI-mediated cleavage of C3b (Chung
et al., 2006). Subsequent studies showed that NS1 can form
a complex with both C1s and C4, causing rapid fluid-phase
consumption of C4 and preventing C4b deposition on the viral
surface (Avirutnan et al., 2010). Finally, NS1 can also bind C4BP
and promote cleavage of C4b, blocking C3 activation via the
CP and LP (Avirutnan et al., 2011). Additionally, mice lacking
C3 or CR1/CR2 genes exhibited suppressed humoral immunity
against WNV (Mehlhop et al., 2005). This multifaceted blockade
of the complement cascade not only prevents direct complement-
mediated viral clearance, but would likely also inhibit T cell
immunity critical for viral clearance, since these responses are
dependent on C3 and the AP (Suthar et al., 2013). Although
direct evidence has only been shown for WNV, it is possible
that NS1 from other flaviviruses use a similar mechanism to
evade complement mediated adaptive immune response. Thus,
future studies should focus on the role of NS1 from other deadly
flaviviruses in directing the host immune defense
Other viruses secrete molecules that directly block
complement activation, which may dampen adaptive immune
responses. For example, the M1 protein from influenza virus
blocks the interaction between IgG and C1q, thereby inhibiting
CP activation of complement (Zhang et al., 2009). Independent
studies showed that blockade of C5aR in an influenza infection
model abrogated CD8+ T cell response (Kim et al., 2004).
Furthermore, mice deficient in C3 exhibited diminished
migration of CD4+ and CD8+ T cells during influenza
infection, resulting in delayed viral clearance and increased viral
titers. CR1/CR2 deficiency had no effect on this phenomenon,
indicating that it is not driven by complement-mediated B cell
stimulation (Kopf et al., 2002). Thus, M1, by inhibiting CP
complement activation, can prevent both complement-mediated
and T cell-mediated clearance of influenza virus.
A recent groundbreaking study showed an intracellular role
of C3, independent of complement activation. After pathogens
tagged with C3 extracellularly (via the canonical complement
activation cascades) are internalized, C3 products are detected,
and triggers NF-κB, IRF-3/5/7, and AP-1 signaling cascades,
leading to the release of proinflammatory cytokines, and
proteosomal degradation of infecting viruses (Tam et al., 2014).
Certain viruses (i.e., rhinovirus and poliovirus) encode proteases
that can degrade opsonizing C3 fragments, promoting their
intracellular survival.
Overall, it is likely that complement inhibition or modulation
on any level will influence adaptive immune responses
against pathogenic organisms. We have described numerous
mechanisms by which regulating opsonization, promoting
complement cleavage, interfering with CR signaling, and direct
engagement of CRs can alter B and T cell responses. Further
studies are required to understand the roles of the diverse array
of immune evasion molecules on the adaptive fitness of their
respective organisms.
PERSPECTIVES
Although complement was once regarded as a self-contained
effector arm of innate immunity, its collaboration with other
immunological phenomena is continually emerging. Indeed,
complement has been long known to bridge innate and
adaptive immunity through the C3d-CR2 interaction, mediating
B cell activation, antigen presentation, and generation of
immunological memory. More recently, complement has been
implicated in driving T cell immunity, both through modulating
cytokine profiles in APCs, as well as through direct engagement
with receptors on and inside T cells. While our view of
complement has expanded dramatically, we have likely just
scratched the surface. In the era of crosstalk between the different
branches of immunity and beyond, many additional roles of
complement are waiting to be discovered.
Complement evasion is well-documented among
microorganisms. Indeed, many immune evasion molecules
have been discovered, and their mechanisms of complement
modulation are now clearly understood. In light of the numerous
links between complement and adaptive immunity, the question
arises as to whether complement evasion molecules modulate
B and T cell responses. In general, there is a relative lack of
studies describing how pathogens exploit complement-mediated
adaptive immunity. This is due, in large part, to the infancy
of the field. Many of these phenomena were discovered within
the last 5–10 years. Additionally, the complexity of these
immune processes makes them difficult to study. Although
some complement evasion molecules are linked to altered T cell
responses, determining the underlying molecular mechanisms
is challenging. Recent advancement in various sequencing,
mouse, and cytometric technologies affords the opportunity
to address these more complex and fundamental questions
regarding complement and T cell biology. However, the species
specificity of many immune evasion molecules makes it difficult
to study their effects in mouse models. Finally, there is the
notion that bacterial immunity is primarily handled by innate
effector functions. Indeed, while viral clearance is primarily
T cell mediated, bacteria are recognized in the extracellular
milieu by pattern recognition molecules and receptors, which
mount a rapid and sometimes aggressive innate immune
response against the invading pathogen. These responses often
also promote adaptive immune responses and the generation
of immunological memory, but historically these responses
are considered secondary to innate immunity. However,
antibodies are often essential for efficient complement activation
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on bacteria. Accordingly, while bacteria have huge arsenals
of virulence factors targeting innate immune components
(including complement), direct evasion of adaptive
immunity seems less prevalent, though it does exist (i.e.,
superantigens of S. aureus). With the continuing discovery
of diverse roles of complement in directing adaptive
immunity, and new tools available to study interactions
of complement and leukocytes, it is likely that many
bacterial complement inhibitors may block B and T cell
responses.
Despite its important role in controlling microbial infections,
complement is also implicated in numerous autoimmune
and inflammatory conditions. Excessive and uncontrolled
complement activation plays a role in many diseases, either
directly (i.e., aHUS, PNH) or indirectly (i.e., RA, SLE, organ
transplantation) (Ricklin and Lambris, 2013; Morgan and Harris,
2015). This activation can also drive adverse adaptive immune
responses. In SLE, for example, complement activation on
damaged or apoptotic cells may lead to generation of autoreactive
antibodies promoted by C3d-CR2 B cell stimulation (Holers,
2014). Additionally, recent evidence has shown that complement
drives both B and T cell responses during transplantation
(Sacks and Zhou, 2012). Thus, microbial evasion molecules
may hold promise for directing complement-mediated adaptive
immune responses for treatment of a new array of disease,
which were previously considered not to be amenable to
complement modulatory strategies. Conversely, the power of
complement can be harnessed to promote favorable adaptive
immune responses. Since the discovery of its adjuvant potential,
C3d has been exploited for development of more potent
vaccines (Toapanta and Ross, 2006). Furthermore, there are
possibilities to leverage known mechanisms of complement-
mediated T cell immunity for treatment of infectious diseases and
cancer.
CONCLUSION
The physiological role of complement has greatly expanded in
recent years. It is now accepted that complement is a crucial
mediator of adaptive immune responses. In addition to its long-
known role in regulating B cell immunity via C3d-CR2, more
recent work has established a multifaceted approach by which
complement drives T cell responses. These mechanisms include
direct engagement between complement activation products with
CRs on T cells, indirect regulation through APC engagement,
and modulation of cytokine profiles through CR-TLR crosstalk.
It is only natural that pathogens, in their struggle for survival,
have developed strategies to overcome these immune pathways.
While numerous evasion mechanisms of complement-mediated
adaptive immunity have been characterized, it is likely that
many other evasion strategies remain undiscovered, including
those mediated by known immune evasion molecules. A better
understanding of pathogenic modulation of complement-
mediated adaptive immunity is prerequisite to capitalizing on the
therapeutic potential of immune evasion molecules.
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